The Montreal Health Innovations Coordinating Center (MHICC) is a full service clinical academic research organization, providing services to the academic community and to the pharmaceutical, biotechnology and medical device industries, in the fields of cardiology, neurology, oncology, dermatology, endocrinology and pharmacogenomics. The MHICC’s flexible, dynamic and fully integrated range of services can handle all Phase II to IV clinical research needs, surpass all regulatory requirements and meet enrollment targets. As a fully integrated Clinical Research Organization (CRO) with deep roots in the academic research and medical worlds, we excel at offering tailor-made services covering any types and phases of clinical trials in the academic, pharmaceutical and biotechnological fields. Our core expertise resides in study project management, data management, site management and biostatistics. Our advantageous positioning as an internationally-acclaimed multi-disciplinary CRO allows you to gain from our specialists’ exclusive scientific backgrounds and technical expertise. Beyond our CRO services, our academic and medical partnerships and service structures allows us to offer timely medical support and academic insights into clinical studies. Furthermore, we offer analytical services from our numerous Core Laboratories such as: • Electrocardiography (ECG) • Intravascular Ultrasound (IVUS) • Quantitative Coronary Angiography • Magnetic Resonance Imaging (MRI) • Brachial Ultrasounds • Cardiovascular Biomarkers • Pharmacogenomics